ArticleExploratory research in clinical and social pharmacy2026
Pharmacist involvement in overweight and obesity care: An equity-focused systematic review.
Article in Exploratory research in clinical and social pharmacy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Pharmacists increasingly contribute to obesity management, but the equity impact of these interventions remained unexplored in literature. Objective: To examine the characteristics and effectiveness of pharmacist-involved weight-management interventions, their consideration of health equity, and the collaborative models through which pharmacists delivered care. Methods: PubMed, Web of Science, Scopus, and the Cochrane Library were searched for English-language quantitative studies published from 2000 to 2026. Eligible studies included people with overweight or obesity, reported weight-related outcomes, and described at least one PROGRESS-Plus characteristic. Equity variables were assessed according to whether they were reported descriptively, used as control variables, or examined for differential effects. Pharmacist collaboration was classified as disciplinary, multidisciplinary, interdisciplinary, or transdisciplinary. Findings were narratively synthesized. Results: Thirty-two studies were included, including 20 conducted in community pharmacies. Pharmacist activities included lifestyle counseling, anthropometric and cardiometabolic monitoring, medication management, adherence support, and referral. Seventeen studies reported significant improvements in BMI or related outcomes. Age and sex were commonly reported, while place of residence, ethnicity, education, employment, socioeconomic status, and social capital were less consistently examined in baseline characteristics. Only seven studies used PROGRESS-Plus factors as control variables, and seven assessed differential effects. Multidisciplinary care was the most common model (50%), followed by interdisciplinary (25%), disciplinary (19%), and transdisciplinary care (6%). Conclusion: Pharmacist-involved interventions may improve weight-related outcomes, but current evidence is insufficient to determine whether they reduce obesity-related inequalities.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.